Logo

Eppendorf Licenses Thermal Cycler IP to Bulldog Bio

Sep 06, 2011

NEW YORK (GenomeWeb News) – Eppendorf has licensed patents covering gradient technology for thermal cyclers to Bulldog Bio, the firms announced today.

The worldwide license covers the GenePro and LifePro gradient thermal cycler products that are sold by Portsmouth, NH-based Bulldog Bio. Terms of the licensing deal were not disclosed.

A Bulldog Bio official said in a statement that the agreement is part of the firm's strategy to "aggressively build the presence of Bulldog Bio in the PCR market."

Filed under

PCR
Business News
licensing agreement
thermal cycler
Eppendorf
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.